About: http://data.cimple.eu/news-article/280a93a137a891b239980a7563bb625666d357c55527e5a9dd0d8e52

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/280a93a137a891b239980a7563bb625666d357c55527e5a9dd0d8e52 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Wall Street stocks gained more than three percent Monday as markets weighed a dire near-term economic outlook against unprecedented federal spending and central bank interventions. The Dow Jones Industrial Average jumped 3.2 percent, or nearly 700 points, to finish the day at 22,327.48. The broad-based S&P 500 gained 3.4 percent to close at 2,626.85, while the tech-rich Nasdaq Composite Index advanced 3.6 percent to 7,774.15. Major indices were in positive territory almost the entire session despite the sharp increase in coronavirus cases in the United States and in other major economies. "Investors might be entering the 'acceptance' phase of the crisis," said JJ Kinahan, chief market strategist at TD Ameritrade. "People know this is going to go on a while and accept what doctors say about how things could get a little worse, but they seem to feel reassured by the Fed and Congress taking quick action to give the economy a security blanket." Polling from Morning Consult showed US consumer confidence remained "relatively stable" over the weekend after President Donald Trump signed a $2 trillion federal relief package. Still, many analysts expect markets to be rocky for the foreseeable future as more terrible economic data surfaces. A note from IHS Markit Monday significantly lowered its forecast for the US economy, projecting a contraction of 5.4 percent in 2020, with a lengthy recovery before returning to pre-pandemic levels. "The risks remain overwhelmingly on the downside and further downgrades are almost assured," IHS said. Big winners in Monday's session included Johnson & Johnson, which won 8.0 percent after announcing that it would begin human trials by September for a vaccine for the coronavirus. Abbott Laboratories gained 6.5 percent as it said it been granted emergency authorization by the Federal Drug Administration approval to begin making available a COVID-19 test that produces results in as little as five minutes. But some embattled travel-oriented stocks fell further, including Expedia, which shed 6.1 percent, and JetBlue and American Airlines, which both lost 10 percent or more. jmb/hs
schema:headline	Dow ends up 3.2% as US stocks finish solidly higher
schema:mentions	Judge S&P 500 Index Dow Jones Industrial Average JetBlue American Airlines Johnson & Johnson Food and Drug Administration United States Congress Vaccine United States Coronavirus President of the United States Donald Trump Coronavirus disease 2019 Comfort object Morning Consult Abbott Laboratories Expedia Christy Kinahan TD Ameritrade IHS Markit Consumer confidence NASDAQ Composite Microsoft Outlook
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-03-30 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	65 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software